56008-20-9

Usage

Uses

Due to the limited information available on 3,6,6-trimethyl-6,7-dihydro-1H-indol-4(5H)-one, it is challenging to provide a comprehensive list of its applications. However, based on its classification as an indole compound, we can infer potential uses in various industries, which may include:
Used in Pharmaceutical Industry:
3,6,6-trimethyl-6,7-dihydro-1H-indol-4(5H)-one could be used as a chemical intermediate or a building block for the synthesis of more complex molecules with potential pharmaceutical applications. Its structure may allow for the development of new drugs or the modification of existing ones to improve their efficacy or reduce side effects.
Used in Chemical Research:
In the field of chemical research, 3,6,6-trimethyl-6,7-dihydro-1H-indol-4(5H)-one may serve as a subject of study for understanding the properties and reactivity of indole compounds. Researchers may explore its potential as a catalyst, ligand, or precursor in various chemical reactions.
Used in Material Science:
3,6,6-trimethyl-6,7-dihydro-1H-indol-4(5H)-one's unique structure may also make it a candidate for the development of new materials with specific properties, such as conductivity, magnetism, or optical activity. It could be used as a component in the synthesis of advanced materials for applications in electronics, energy storage, or sensing technologies.

Upstream product

• 129689-88-9 3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indole-2-carboxylic acid 
• 31915-82-9 (Z)-2-oxopropanal oxime 
• 126-81-8 dimedone 
• 17280-41-0 anti-pyruvic aldehyde 1-oxime 
• 306-44-5 propanone 1-oxime 
• 37711-24-3 ethyl 4-oxo-3,6,6-trimethyl-4,5,6,7-tetrahydro-1H-indole-2-carboxylate 

Downstream Products

• 1595028-22-0 8-(4-methoxyphenyl)-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)-3,4-dihydroisoquinolin-1(2H)-one 
• 1595028-20-8 8-(3-fluorophenyl)-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)-3,4-dihydroisoquinolin-1(2H)-one 
• 1595028-18-4 8-(4-fluorophenyl)-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)-3,4-dihydroisoquinolin-1(2H)-one 
• 1595028-16-2 8-phenyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)-3,4-dihydroisoquinolin-1(2H)-one 
• 1595028-14-0 8-benzyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)-3,4-dihydroisoquinolin-1(2H)-one 
• 1595028-04-8 8-cyclohexyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)-3,4-dihydroisoquinolin-1(2H)-one 
• 1432508-44-5 N-hydroxy-4-((3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)methyl)benzamide 
• 1432509-59-5 methyl 4-((3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indole-1-yl)methyl)benzoate 
• 1073973-63-3 2-((1S,2S)-2-(benzyloxy)cyclopentylamino)-6-fluoro-4-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)benzonitrile 
• 1073973-24-6 2-fluoro-6-((S)-tetrahydro-furan-3-ylamino)-4-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-indol-1-yl)-benzonitrile 

Relevant academic research and scientific papers

OMEGA-AMINO ACID DERIVATIVES OF BENZENE, PYRIDINE, AND PYRIDAZINE COMPOUNDS

Disclosed are compounds and pharmaceutically acceptable salts of Formula I wherein R1, R2, R3, R4, R5, R6, R7, n, Q1, Q2, Q3, Y, and X1/sub

HYDROXAMATE DERIVATIVES FOR HDAC INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THEREOF

The present invention relates to a novel hydroxamate derivatives, more specifically, to novel hydroxamate derivatives having inhibitory activity against Histone Deacetylase (HDAC), isomers thereof, pharmaceutically acceptable salts thereof, hydrates or solvates thereof, use for preparing pharmaceutical compositions, pharmaceutical compositions comprising the same, treatment method using said composition, and a preparing method of novel hydroxamate derivatives. The novel selective hydroxamate derivatives having inhibitory activity against Histone Deacetylase (HDAC) compositions can be used for treatment of inflammatory disease, rheumatoid arthritis, or degenerative disease.

HYDROXAMATE DERIVATIVES FOR HDAC INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THEREOF

The present invention relates to a novel hydroxamate derivatives, more specifically, to novel hydroxamate derivatives having inhibitory activity against Histone Deacetylase (HDAC), isomers thereof, pharmaceutically acceptable salts thereof, hydrates or solvates thereof, use for preparing pharmaceutical compositions, pharmaceutical compositions comprising the same, treatment method using said composition, and a preparing method of novel hydroxamate derivatives. The novel selective hydroxamate derivatives having inhibitory activity against Histone Deacetylase (HDAC) compositions can be used for treatment of inflammatory disease, rheumatoid arthritis, or degenerative disease.

Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents

A novel class of heat shock protein 90 (Hsp90) inhibitors was developed from an unbiased screen to identify protein targets for a diverse compound library. These indol-4-one and indazol-4-one derived 2-aminobenzamides showed strong binding affinity to Hsp

Tetrahydroindole and Tetrahydroindazole Derivatives

The invention provides indole and indazole compounds of Formula (I) or pharmaceutically acceptable salts thereof which are useful for treating and/or preventing diseases and/or disorders ameliorated by the inhibition of Heat-Shock Protein 90. The invention further provides pharmaceutical compositions comprising compounds of Formula (I) and methods of preparing compounds of Formula (I).

Cyclohexylamino Benzene, Pyridine, and Pyridazine Derivatives

Disclosed are compounds and pharmaceutically acceptable salts of Formula (I), wherein Q1, Q2, RN, R1, R2, R5, R6, R7, R8, X1, X2, Xsu

TETRAHYDROINDOLONE AND TETRAHYDROINDAZOLONE DERIVATIVES

Disclosed are compounds and pharmaceutically acceptable salts of Formula (I): wherein R1, R2, R3, R4, R5, R6, R7, n, Q1, Q2, Q3, Y, and X1-X4 are as defined

The Chemistry of Pyrrolic Compounds. LXIII Synthetic Studies of Petroporphyrins with Fused Six-Membered Ring Systems

Several approaches to the synthesis of porphyrins bearing fused six-membered ring systems were explored with the aim of obtaining the petroporphyrin (4a).This was ultimately achieved by an intramolecular cyclization of a porphyrin with a propanoyl chloride side chain in the presence of stannic chloride.Methylation of the intermediate ketone with CH3Li and reduction of the resultant alcohol with NaBH3CN/ZnI furnished (4a).